HeimMDT • NYSE
add
Medtronic PLC
Við síðustu lokun
82,68 $
Dagbil
80,51 $ - 82,49 $
Árabil
75,96 $ - 92,68 $
Markaðsvirði
103,43 ma. USD
Meðalmagn
6,11 m.
V/H-hlutf.
24,61
A/V-hlutfall
3,47%
Aðalkauphöll
NYSE
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(USD) | okt. 2024info | Breyting á/á |
---|---|---|
Tekjur | 8,40 ma. | 5,25% |
Rekstrarkostnaður | 3,78 ma. | 2,30% |
Nettótekjur | 1,27 ma. | 39,71% |
Hagnaðarhlutfall | 15,11 | 32,66% |
Hagnaður á hvern hlut | 1,26 | 0,80% |
EBITDA | 2,36 ma. | 6,70% |
Virkt skatthlutfall | 18,01% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(USD) | okt. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 7,99 ma. | 3,30% |
Heildareignir | 90,04 ma. | -0,05% |
Heildarskuldir | 41,33 ma. | 7,51% |
Eigið fé alls | 48,72 ma. | — |
Útistandandi hlutabréf | 1,28 ma. | — |
Eiginfjárgengi | 2,19 | — |
Arðsemi eigna | 4,68% | — |
Ávöxtun eigin fjár | 5,50% | — |
Peningaflæði
Breyting á handbæru fé
(USD) | okt. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | 1,27 ma. | 39,71% |
Handbært fé frá rekstri | 958,00 m. | 44,93% |
Reiðufé frá fjárfestingum | -345,00 m. | 18,63% |
Reiðufé frá fjármögnun | -534,00 m. | -493,33% |
Breyting á handbæru fé | 83,00 m. | 396,43% |
Frjálst peningaflæði | 748,25 m. | 16,23% |
Um
Medtronic plc is an American-Irish medical device company. The company's operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue.
Medtronic's pioneering innovations have transformed healthcare through ground-breaking medical devices. The company has developed several world-first technologies since its inception, including wearable and implantable pacemakers, the implantable cardioverter defibrillator, and remote monitoring systems. They also created breakthrough solutions in diabetes care with the first 24-hour automated insulin delivery, deep brain stimulation, and miniaturized devices like the world's smallest pacemaker and spinal cord stimulator. Wikipedia
Framkvæmdastjóri
Stofnsett
1949
Vefsvæði
Starfsfólk
95.000